The startup has developed a single-use disposable fluid therapy device that prevents accidental disconnection of IV medications by incorporating dual check valves and filtration to eliminate microbes and particulates. This technology enhances patient safety by reducing the risk of bloodstream infections during intravenous fluid management.
Funding
$500K raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Healthcare-associated infections (HAIs) from contaminated intravenous (IV) lines pose a significant risk to patient safety, with millions of IV lines placed annually in the US and a notable percentage leading to catheter-related bloodstream infections. Current methods of IV medication administration lack closed-loop designs and sufficient filtration, while rapid sequencing of multiple medications in settings like anesthesia makes proper port cleaning between medications challenging. Existing IV access ports often lack check valves, increasing the risk of retrograde fluid dilution or co-mixing of medications.
Solution
HAI Solutions develops innovative vascular access devices designed to reduce contamination and improve patient safety during intravenous medication administration. Their Multiport Delivery Device (MDD) features multiple IV ports with integrated filters for variable fluid viscosity, regulated by a high-pressure check valve system to prevent reflux and ensure proper fluid delivery. The QIKcap Disinfection Device utilizes UVC technology and a chromatic luer cap to rapidly disinfect the septum surface of IV connectors, preventing microbial ingress. These devices aim to address the limitations of current IV access methods by providing closed systems, improved filtration, and rapid disinfection capabilities.
Target Audience
The primary target audience includes anesthesiologists, nurses, and other healthcare providers in operating rooms, emergency rooms, and intensive care units who administer intravenous medications and seek to reduce the risk of healthcare-associated infections.
Features
- **Multiport Delivery Device (MDD):**
- Multiport access for simultaneous administration of multiple IV medications
- Integrated dual-filter design for filtering pharmaceutical fluid particulates, entrapped air, and microbial contamination
- Anti-reflux valves to prevent retrograde fluid medication flow and anti-siphon prevention of retrograde blood flow
- Self-priming feature to purge air molecules from the IV line
- High-pressure check valve system to maintain regulated pressure and minimize precipitates
- **QIKcap Disinfection Device (QDD):**
- UVC technology for rapid septum surface disinfection
- Chromatic dosimeter to ensure proper irradiation
- Handheld, lightweight, and ergonomic design
- Single-use disposable IV connector cap with chromatic dosimeter and lens
- Software-driven device built on a scalable digital health platform